Medication info
Withus Famotidine Tablets 20mg

Withus Famotidine Tablets 20mg

Prescription medicationTablet
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Withus Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 198802273 · Notified 1988.10.10 · Insurance code 660701370

Summary

Main use
Treatment of acid-related disorders (ulcers, etc.), upper gastrointestinal bleeding and gastritis; improvement of preanesthetic medication
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take famotidine 20mg per dose, 2 times daily (after breakfast, after dinner, or at bedtime) orally, or 40mg per dose, once daily (at bedtime) orally. For upper gastrointestinal bleeding, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration. 2. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Take famotidine 10mg per dose, 2 times daily (after breakfast, after dinner, or at bedtime) orally, or 20mg per dose, once daily (at bedtime) orally. Adjust the dose appropriately according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine per dose in 20ml of physiological saline injection or glucose injection and administer by slow intravenous injection 2 times daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, the effect generally appears within 1 week; once oral administration is possible, switch to oral administration. When used as preanesthetic medication, dissolve 20mg per dose in 1-1.5ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve it in 20ml of physiological saline injection or glucose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose appropriately according to age and symptoms.

Ingredients

Manufacturer
Withus Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, etc.), upper gastrointestinal bleeding and gastritis; improvement of preanesthetic medication

  • Gastric and duodenal ulcers
  • anastomotic ulcers
  • upper gastrointestinal bleeding
  • acute stress ulcers
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • acute gastritis
  • acute exacerbations of chronic gastritis.
View approved original text

This medication is effective in the treatment of gastric and duodenal ulcers, anastomotic ulcers, and upper gastrointestinal bleeding associated with peptic ulcers. It is also used for improving conditions of excessive gastric acid secretion such as gastroesophageal reflux disease and Zollinger-Ellison syndrome. It alleviates gastric mucosal damage due to acute exacerbations of acute and chronic gastritis and helps treat lesions of the gastric mucosa such as erosion, bleeding, and swelling. As an injectable form, it is also utilized prior to anesthesia to reduce the risk of gastrointestinal bleeding. In summary, this drug is used for the treatment of various gastrointestinal diseases and for the protection of gastric mucosa.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger-Ellison syndrome: Adults should take famotidine 20mg per dose, 2 times daily (after breakfast, after dinner, or at bedtime) orally, or 40mg per dose, once daily (at bedtime) orally. For upper gastrointestinal bleeding, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration. 2. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Take famotidine 10mg per dose, 2 times daily (after breakfast, after dinner, or at bedtime) orally, or 20mg per dose, once daily (at bedtime) orally. Adjust the dose appropriately according to age and symptoms. (Injection) Adults: Dissolve 20mg of famotidine per dose in 20ml of physiological saline injection or glucose injection and administer by slow intravenous injection 2 times daily (every 12 hours), or mix with an infusion solution and administer by intravenous drip. For upper gastrointestinal bleeding and Zollinger-Ellison syndrome, the effect generally appears within 1 week; once oral administration is possible, switch to oral administration. When used as preanesthetic medication, dissolve 20mg per dose in 1-1.5ml of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve it in 20ml of physiological saline injection or glucose injection and administer by slow intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose appropriately according to age and symptoms.

Precautions

This medication should not be used in patients who have previously shown allergic reactions to its ingredients or other H2 receptor antagonists. Patients with drug hypersensitivity, impaired renal function, heart disease, liver dysfunction, and elderly individuals should exercise special caution when using this drug. Particularly in cases of poor renal function, the drug may remain in the body longer, increasing the risk of side effects; thus, the dosage should be reduced or the administration interval extended. Rarely, this medication may cause serious side effects such as shock, severe allergic reactions, hematological abnormalities, severe skin diseases, hepatic dysfunction, muscle damage, heart rhythm abnormalities, altered consciousness, nephritis, and pneumonia. If any abnormal symptoms appear, the use of the medication should be discontinued immediately, and medical treatment should be sought. Additionally, various mild side effects such as constipation, diarrhea, nausea, vomiting, headache, drowsiness, insomnia, dizziness, and arthralgia may occur, so symptoms should be carefully monitored. During treatment, it is advisable to use the minimum effective dosage while closely observing changes in symptoms, and to switch to alternative treatment if no effect is observed. This medication dissolves in the oral cavity but is not absorbed through the oral mucosa, so it must be swallowed with saliva or water. Patients undergoing hemodialysis should be cautious as the efficacy of calcium supplements may be diminished when this drug is used together with phosphate binders. This medication may reduce the efficacy of certain antifungals or some anticancer agents when taken together; therefore, any other medications being used should be disclosed to the doctor or pharmacist. Elderly patients are more likely to have reduced kidney function, which can increase the blood concentration of this medication; hence, dosage adjustments or extended intervals may be necessary. Women who are pregnant or may become pregnant should use this medication only if the benefits outweigh the risks, as safety has not been fully established. Women who are breastfeeding are advised to discontinue breastfeeding as this medication can pass into breast milk. Safety in children has not been fully established, so caution should be exercised when administering to youngsters. Finally, this medication may mask symptoms of gastric cancer, making diagnosis difficult; therefore, it should only be used after confirming a non-malignant condition.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • generalized flushing
  • angioedema
  • facial swelling
  • pharyngeal swelling
  • urticaria
  • pancytopenia
Show 80 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • general malaise
  • weakness
  • subcutaneous and mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • mucosal erosion syndrome
  • Reille syndrome
  • toxic epidermal necrolysis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized seizures
  • tonic seizures
  • clonic seizures
  • interstitial nephritis
  • acute renal failure
  • rash
  • papule
  • high fever
  • cough
  • dyspnea
  • interstitial pneumonia
  • inadequate contraction
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • soft stools
  • dryness of the mouth
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • hypertension
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • general malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • paresthesia
  • heaviness in the head
  • reversible confusional state
  • depression
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is light-sensitive and should be stored in a container that blocks light. It is also essential to store it at room temperature between 1 to 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.